with high reproducibility at the raw data level (Supplementary Fig. 1 peptide sequences were identified for each protein (Fig. 1B) . Several proteins were identified 161 with over 200 peptides (Fig. 1C) . The proteins excluded by DIA-expert may not be incorrect 162 identifications, but rather proteins that could not achieve reproducible quantification by the 163 existing algorithm across all cell lines due to either technical issues, for instance the signal-to-164 noise ratio, or biological issues such as post-translational modifications and splicing variants.
165
Improved computational methods will likely rescue some of them in the future. Figure 3) . The landscape of the 120 thus measured proteotypes is displayed in Fig. 2A Fig. 6-7) . Table 6 ). We generated various combinations of molecular features, and (Fig. 3D) . We also compared the predictive power of the DDA data to the SWATH data.
364
While the DDA data were able to generate elastic net models for comparable number of drugs 365 (Fig. 3E) , the number of protein predictors is much lower than SWATH data over some 366 overlap (Fig. 3F) . Based on the integration of various data sets, global drug response patterns were 371 predicted for the 158 well-modeled drugs (Fig. 4, 
390
Sensitivity to the antimetabolite 6-thioguanine (6-TG, NSC: 752) (Fig. 5A) was Still, we find that for the two strongest predictors in the model, NUDT5 and MAT2B, the 396 expression data were significantly correlated with the activity of 6-TG ( Fig. 5B and 5C ).
397
Additionally, we were able to relate the inter-connected activities of these two proteins to the 398 mechanism of action for 6-TG. In the purine salvage pathway, HPRT1 catalyzes synthesis of ME:SK-MEL-5 and ME:LOXIMVI, which are relatively resistant to Vemurafenib (Fig. 5G) . 
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SWATH-MS
676
The SWATH-MS data acquisition in a Sciex TripleTOF 5600 mass spectrometer was The activity of pathways, as they are described in ACSN, has been computed using Elastic net analysis was done using the glmnet R package 79 . The elastic net analysis 767 was conducted using a multi-step pipeline involving cross-validations performed in a nested 768 manner. The "outer" cross-validation is a leave-one-out cross validation that is conducted 769 over all computational steps present in the "inner" pipeline, and it is used to validate model 770 performance. The "inner" cross-validation are conducted to select elastic net hyperparameters
771
(alpha and lambda) and for predictor set trimming, using data from a set of ~59 cell lines.
773
The elastic net parameters alpha and lambda were selected by minimizing the cross- To obtain a robust estimate of performance on unseen data, leave-one-out cross-
785
validation was applied to the overall procedure as part of the "outer" pipeline. Specifically,
786
drug response for each cell line was predicted using an elastic net model derived using the 787 remaining held out data (and the steps outlined above). 
